Msd Drug Patent Portfolio
Msd owns 2 orange book drugs protected by 7 US patents Given below is the list of Msd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9604948 | Process for preparing substituted 5-fluoro-1H-pyrazolopyridines | 26 Nov, 2032 | Active |
| US10736896 | Substituted 5-fluoro-1H-pyrazolopyridines and their use | 19 May, 2031 | Active |
| US11439642 | Substituted 5-fluoro-1H-pyrazolopyridines and their use | 19 May, 2031 | Active |
| US8420656 | Substituted 5-fluoro-1H-pyrazolopyridines and their use | 19 May, 2031 | Active |
| US8921377 | Substituted 5-fluoro-1H-pyrazolopyridines and their use | 19 May, 2031 | Active |
| US9993476 | Substituted 5-flouro-1H-pyrazolopyridines and their use | 19 May, 2031 | Active |
| USRE46791 | Substituted dihydroquinazolines | 18 Jan, 2029 | Active |
Latest Legal Activities on Msd's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Msd.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 01 May, 2024 | US10603384 |
|
Email Notification
Critical
| 30 Apr, 2024 | US10603384 |
| Recordation of Patent eCertificate of Correction | 30 Apr, 2024 | US10603384 |
| Patent eCofC Notification | 30 Apr, 2024 | US10603384 |
| Mail Patent eCofC Notification | 30 Apr, 2024 | US10603384 |
| Post Issue Communication - Certificate of Correction | 10 Apr, 2024 | US10603384 |
|
Withdrawal of Application for PTE
Critical
| 07 Feb, 2024 | US8513255 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Jan, 2024 | US10736896 |
| Election in Response to Notice of Final Determination | 27 Dec, 2023 | US8513255 |
| Notice of Final Determination -Election Required | 14 Dec, 2023 | US8513255 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 12 Sep, 2023 | US10603384 |
|
FDA Final Eligibility Letter
Critical
| 13 Jul, 2023 | US8513255 |
| Second letter to regulating agency to determine regulatory review period | 15 Jun, 2023 | US8420656 |
| Second letter to regulating agency to determine regulatory review period | 15 Jun, 2023 | US9604948 |
| Letter from FDA or Dept of Agriculture re PTE application | 03 Oct, 2022 | US8420656 |
Msd's Family Patents
Msd Drug List
Given below is the complete list of Msd's drugs and the patents protecting them.
1. Prevymis
Prevymis is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| USRE46791 | Substituted dihydroquinazolines |
18 Jan, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prevymis's drug page
2. Verquvo
Verquvo is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9604948 | Process for preparing substituted 5-fluoro-1H-pyrazolopyridines |
26 Nov, 2032
(7 years from now)
| Active |
| US10736896 | Substituted 5-fluoro-1H-pyrazolopyridines and their use |
19 May, 2031
(6 years from now)
| Active |
| US11439642 | Substituted 5-fluoro-1H-pyrazolopyridines and their use |
19 May, 2031
(6 years from now)
| Active |
| US8420656 | Substituted 5-fluoro-1H-pyrazolopyridines and their use |
19 May, 2031
(6 years from now)
| Active |
| US8921377 | Substituted 5-fluoro-1H-pyrazolopyridines and their use |
19 May, 2031
(6 years from now)
| Active |
| US9993476 | Substituted 5-flouro-1H-pyrazolopyridines and their use |
19 May, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Verquvo's drug page